Nolicin (Norfloxacin)

Norfloxacin, the active ingredient in Nolicin, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It treats uncomplicated urinary tract infections, acute bacterial prostatitis, gastrointestinal infections such as traveler's diarrhea, and respiratory tract infections in adult patients.

GNH USA supplies Nolicin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Noricin is a fluoroquinolone antibacterial that targets a range of bacterial infections in the urinary, genitourinary, gastrointestinal and respiratory systems.

Uncomplicated urinary tract infection: eradicates the causative bacteria and resolves urinary symptoms. Acute bacterial prostatitis: penetrates prostatic tissue to eliminate infection and reduce inflammation. Gastrointestinal infection (traveler's diarrhea): controls pathogenic bacteria causing acute diarrhoea. Respiratory tract infection: treats susceptible bacterial pathogens in the upper and lower airways.

Noricin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea or vomiting - Diarrhoea - Headache - Dizziness - Abdominal discomfort - Skin rash

Serious or Rare Side Effects: - Tendon rupture or inflammation - QT interval prolongation leading to cardiac arrhythmia - Severe allergic reactions such as anaphylaxis - Clostridioides difficile‑associated colitis - Hepatic dysfunction - Peripheral neuropathy

Before prescribing Noricin, clinicians should consider several safety aspects.

Assess renal function: adjust therapy in patients with severe impairment. Avoid use in patients with known tendon disorders: risk of tendon rupture. Monitor cardiac status: caution in individuals with QT‑prolonging risk factors. Use with caution in pregnancy: category C, discuss potential risks with the patient. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Noricin can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Antacids containing aluminium, magnesium or calcium: reduce absorption of norfloxacin. - Warfarin: may increase anticoagulant effect and bleeding risk. - Other QT‑prolonging agents: additive risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: heightened central nervous system side effects. - Systemic corticosteroids: increased risk of tendon injury. - CYP1A2 inhibitors (e.g., ciprofloxacin): may raise norfloxacin plasma levels.